Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Laser-induced differential normalized fluorescence method for cancer diagnosis

Patent ·
OSTI ID:415747

An apparatus and method for cancer diagnosis are disclosed. The diagnostic method includes the steps of irradiating a tissue sample with monochromatic excitation light, producing a laser-induced fluorescence spectrum from emission radiation generated by interaction of the excitation light with the tissue sample, and dividing the intensity at each wavelength of the laser-induced fluorescence spectrum by the integrated area under the laser-induced fluorescence spectrum to produce a normalized spectrum. A mathematical difference between the normalized spectrum and an average value of a reference set of normalized spectra which correspond to normal tissues is calculated, which provides for amplifying small changes in weak signals from malignant tissues for improved analysis. The calculated differential normalized spectrum is correlated to a specific condition of a tissue sample. 5 figs.

Research Organization:
Lockheed Martin Energy Syst Inc
DOE Contract Number:
AC05-84OR21400
Assignee:
Martin Marietta Energy Systems, Inc., Oak Ridge, TN (United States)
Patent Number(s):
US 5,579,773/A/
Application Number:
PAN: 8-316,132
OSTI ID:
415747
Country of Publication:
United States
Language:
English

Similar Records

Laser-induced differential normalized fluorescence method for cancer diagnosis
Patent · Sun Dec 31 23:00:00 EST 1995 · OSTI ID:870708

Laser-induced differential fluorescence for cancer diagnosis without biopsy
Journal Article · Tue Dec 31 23:00:00 EST 1996 · Applied Spectroscopy · OSTI ID:662001

Cancer detection using NIR elastic light scattering and tissue fluorescence imaging
Conference · Sun Dec 03 23:00:00 EST 2000 · OSTI ID:15005829